Literature DB >> 30221252

When nucleoside chemistry met hypervalent iodine reagents.

Mahesh K Lakshman1, Barbara Zajc1.   

Abstract

There has been increasing use of hypervalent iodine reagents in the field of n class="Chemical">nucleoside chemistry. Applications span: (a) synthesis of nucleoside analogues with sulfur and seleno sugar surrogates, (b) synthesis of unusual carbocyclic and ether ring-containing nucleosides, (c) introduction of sulfur and selenium into pyrimidine bases of nucleosides and analogues, (d) synthesis of isoxazole and isoxazoline ring-containing nucleoside analogues, (e) involvement of purine ring nitrogen atoms for remote C-H bond oxidation, and (f) metal-catalyzed and uncatalyzed synthesis of benzimidazolyl purine nucleoside analogues by intramolecular C-N bond formation. This review offers a perspective on developments involving the use of hypervalent iodine reagents in the field of nucleoside chemistry that have appeared in the literature in the 2003-2017 time frame.

Entities:  

Keywords:  C-H bond activation; C-N bond formation; hypervalent iodine; nucleoside analogs; nucleosides

Year:  2017        PMID: 30221252      PMCID: PMC6135263          DOI: 10.24820/ark.5550190.p010.281

Source DB:  PubMed          Journal:  ARKIVOC            Impact factor:   1.140


  31 in total

Review 1.  Nucleoside antibiotics: structure, biological activity, and biosynthesis.

Authors:  K Isono
Journal:  J Antibiot (Tokyo)       Date:  1988-12       Impact factor: 2.649

2.  Introduction of a hydroxy group at the para position and N-iodophenylation of N-arylamides using phenyliodine(III) bis(trifluoroacetate).

Authors:  Naoki Itoh; Takeshi Sakamoto; Etsuko Miyazawa; Yasuo Kikugawa
Journal:  J Org Chem       Date:  2002-10-18       Impact factor: 4.354

3.  N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.

Authors:  Lak Shin Jeong; Dong Zhe Jin; Hea Ok Kim; Dae Hong Shin; Hyung Ryong Moon; Prashantha Gunaga; Moon Woo Chun; Yong-Chul Kim; Neli Melman; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2003-08-28       Impact factor: 7.446

4.  Pioneering Metal-Free Oxidative Coupling Strategy of Aromatic Compounds Using Hypervalent Iodine Reagents.

Authors:  Yasuyuki Kita; Toshifumi Dohi
Journal:  Chem Rec       Date:  2015-07-29       Impact factor: 6.771

5.  A new entry to carbocyclic nucleosides: oxidative coupling reaction of cycloalkenylsilanes with a nucleobase mediated by hypervalent iodine reagent.

Authors:  Yuichi Yoshimura; Masatoshi Ohta; Tatsushi Imahori; Tomozumi Imamichi; Hiroki Takahata
Journal:  Org Lett       Date:  2008-07-10       Impact factor: 6.005

6.  Bimetallic palladium catalysis: direct observation of Pd(III)-Pd(III) intermediates.

Authors:  David C Powers; Matthias A L Geibel; Johannes E M N Klein; Tobias Ritter
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

7.  New RNA purine building blocks, 4'-selenopurine nucleosides: first synthesis and unusual mixture of sugar puckerings.

Authors:  Jinha Yu; Jin-Hee Kim; Hyuk Woo Lee; Varughese Alexander; Hee-Chul Ahn; Won Jun Choi; Jungwon Choi; Lak Shin Jeong
Journal:  Chemistry       Date:  2013-03-28       Impact factor: 5.236

Review 8.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

9.  Purinyl N1-directed aromatic C-H oxidation in 6-arylpurines and 6-arylpurine nucleosides.

Authors:  Raghu Ram Chamala; Damon Parrish; Padmanava Pradhan; Mahesh K Lakshman
Journal:  J Org Chem       Date:  2013-07-11       Impact factor: 4.354

10.  A novel method for the synthesis of 4'-thiopyrimidine nucleosides using hypervalent iodine compounds.

Authors:  Naozumi Nishizono; Ryosuke Baba; Chika Nakamura; Kazuaki Oda; Minoru Machida
Journal:  Org Biomol Chem       Date:  2003-11-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.